Stoke Therapeutics, Inc. (STOK): 424B5 filed Aug 3, 2026

Form type

424B5

Filing date

Aug 3, 2026

Accession number

0001193125-26-330792

Filer

Stoke Therapeutics, Inc. (CIK 1623526)